Distinct evolutionary regimes across domains of the Plasmodium falciparum CSP gene
Malaria disease caused by parasites of genus Plasmodium places an enormous disease burden across tropical regions of the world. The circumsporozoite protein (CSP) of Plasmodium has several key functions in binding and accessing host cells, with functions subdivided across multiple protein regions. While its key roles during infection make the gene a primary target for malaria vaccine development, the evolutionary dynamics that could affect the forecasting of useful strains remain poorly understood. We tested whether the gene undergoes multiple DNA substitution processes and whether these are divided across gene regions using a phylogenetic mixture model, and a global sample of CSP sequences specific to P. falciparum. These analyses reveal evolutionary processes unique to the central repeat region and the C-terminus. The central repeat region is dominated by synonymous substitutions (putatively neutral) and heavy C-T substitution bias, while the C-terminus undergoes mostly non-synonymous changes. These evolutionary processes are not strongly geographically restricted, and lineages from Africa and Asia where the parasite is most abundant appear to drive evolution across all CSP gene regions. We propose that insights about DNA substitution processes can help forecast the variants of importance to vaccine development, aided by state-of-the-art evolutionary modelling.
Authors
- David Alejandro Duchêne (ORCID: https://orcid.org/0000-0002-5479-1974)
- Samir Bhatt (ORCID: https://orcid.org/0000-0002-0891-4611)
- Rusul Al-Kaisy
Institutions
- University of Copenhagen (DK)
- London Centre for Neglected Tropical Disease Research (GB)
Publication Details
- Journal
- Scientific Reports
- Published
- 2025-04-18
- DOI
- https://doi.org/10.1038/s41598-025-98456-4
- Citations
- 1
- Primary Topic
- Malaria Research and Control
- Type
- article
- Field-Weighted Citation Impact
- 1.88
Funders
- London School of Hygiene and Tropical Medicine
- National Institute for Health Research Health Protection Research Unit
- National Institute for Health and Care Research
- Department of Health and Social Care
- Imperial College London
- European Commission
- National Research Foundation
- Danmarks Grundforskningsfond
- Novo Nordisk
- Novo Nordisk Fonden
- Foreign, Commonwealth and Development Office
- Medical Research Council
- European and Developing Countries Clinical Trials Partnership